Methods and compositions including methscopolamine bromide
AssigneeVictory Pharma, Inc.
InventorDavid Preston
Life of this patent
Estimating the term…
Abstract
Therapeutic pharmaceutical compositions are provided that include an anticholinergic agent and a sedative agent. Particularly preferred anticholinergic agents include anticholinergic agents which do not substantially cross the blood-brain barrier. Methscopolamine bromide is the preferred anticholinergic agent. The sedative agent may be chlordiazepoxide hydrochloride or diazepam. Various methods using the compositions to alleviate gastrointestinal disorders or symptoms thereof are also provided.
Claims28
A therapeutic pharmaceutical composition consisting essentially of a therapeutically effective amount of a blended mixture of an anticholinergic agent comprising methscopolamine bromide and a sedative agent comprising chlordiazepoxide hydrochloride.
A therapeutic pharmaceutical composition consisting essentially of a therapeutically effective amount of a blended mixture of an anticholinergic agent comprising methscopolamine bromide and a sedative agent comprising diazepam.
A therapeutic pharmaceutical composition consisting essentially of a therapeutically effective amount of a blended mixture of methscopolamine bromide and chlordiazepoxide hydrochloride wherein the ratio of the methscopolamine bromide to the chlordiazepoxide is about 0.5:1 to about 1:1.
A method of alleviating at least one gastrointestinal disorder or at least one symptom of a gastrointestinal disorder in a human patient, the method comprising administering to the patient a therapeutic pharmaceutical composition consisting essentially of a therapeutically effective amount of a blended mixture of methscopolamine bromide and chlordiazepoxide hydrochloride.
A method of alleviating at least one gastrointestinal disorder or at least one symptom of a gastrointestinal disorder in a human patient, the method comprising administering to the patient a therapeutic pharmaceutical composition consisting essentially of a therapeutically effective amount of a blended mixture of methscopolamine bromide and diazepam.
Dependencies are inferred from the claim text.